🎙️ Final episode of our #AAIC25 Podcasts! Highlights include sleep & dementia risk, blood-based biomarkers, and the rise of AI in research. Guests: Dr Shea Andrews, Dr Joe Butler, Dr Lindsey Sinclair & @hdemnitzking.bsky.social
pod.fo/e/306803
@chrisbintener.bsky.social
Project Officer at Alzheimer Europe #Gerontologist communicating about #neurodegeneration #dementia & related topics. @IHI-PROMINENT.bsky.social @fluidx-ad.bsky.social
🎙️ Final episode of our #AAIC25 Podcasts! Highlights include sleep & dementia risk, blood-based biomarkers, and the rise of AI in research. Guests: Dr Shea Andrews, Dr Joe Butler, Dr Lindsey Sinclair & @hdemnitzking.bsky.social
pod.fo/e/306803
Our second #AAIC25 special is live! Dr James Brady with @stirlandia.bsky.social, @isabelscst.bsky.social & @felixwittmann.bsky.social. Video & audio streaming now.
pod.fo/e/304afe
Lifestyle Interventions to Improve Cognition in Later Life
Editorial from @jama.com: The US POINTER study suggests that modest lifestyle interventions can enhance cognitive health in aging populations, offering a practical and cost-effective approach to dementia prevention.
ja.ma/3IIrv0f
#AAIC2025
🧠On #WorldBrainDay #WBD2025 we highlight FluiDx-AD, improving early Alzheimer’s diagnosis with saliva & blood-based tests.
Led by Oslo University Hospital & Pre Diagnostics, with Alzheimer Europe leading on communication & Public Involvement.
🎥 vimeo.com/1058971988
🔗 linktr.ee/FluiDx_AD
🧠Today on #WorldBrainDay #WBD2025, we highlight the @ihieurope.bsky.social funded @ihi-prominent.bsky.social project, creating a digital platform for precision medicine in Alzheimer’s disease.
vimeo.com/835447757
🔗 www.ihi-prominent.eu
A promotional graphic from Alzheimer Europe inviting European residents aged 18 and over to take part in a public opinion poll on dementia research. The image is set on a blue background and includes the Alzheimer Europe logo in the top right corner. On the left side, there is a stylised mobile phone screen with a QR code and the text: “Scan here to participate!”. Below it reads: “Results will be published on the Alzheimer Europe website in October 2025.” On the right side, a blue speech bubble contains key information about the poll: “We are inviting all European residents (aged 18+) to take part in our public opinion poll.” “No prior experience with dementia research needed” “Available in 12 languages” “Takes approximately 10 minutes to complete” “Your input will help shape future research and data sharing” At the top left, a brain icon is followed by the heading: “Tell us what you think about dementia research!”
Alzheimer Europe’s public opinion poll about attitudes and perceptions on dementia research and data sharing is still open. Participate today to help shape the future of #dementia research! alzheimereurope.qualtrics.com/jfe/form/SV_...
14.07.2025 09:25 — 👍 0 🔁 1 💬 0 📌 0Want to know more?
Check out our spotlight on early career researchers interview with first author Xin Xia: www.ihi-prominent.eu/spotlight-on...
What are the predictive objectives, constituting predictors and algorithms, as well as the performance of existing multimodal prediction models for Alzheimer's disease?
Have a read of our latest scoping review funded through @ihieurope.bsky.social: journals.sagepub.com/doi/10.1177/...
Younger generations less likely to have dementia, study suggests
02.06.2025 15:06 — 👍 95 🔁 12 💬 10 📌 4The @ihieurope.bsky.social funded @ihi-prominent.bsky.social Newsletter #4 is out now.
Highlights 🌟EU authorises lecanemab for early Alzheimer’s, clinician survey on decision support, latest biomarker research & European Parliament debate.
Read & subscribe: mailchi.mp/266ae009900a...
Die Aufzeichnung unseres Lunchtalks mit @mss7676.bsky.social ist jetzt auf unserem YouTube-Kanal verfügbar. Im Gespräch ging es u.a. darum, wie #KI wissenschaftliches Arbeiten verändert, was das für die #Wisskomm bedeutet und welche Kompetenzen wichtig für AI literacy sind:
youtu.be/w2R0PmmAA9c
🚨 EMA issued a negative opinion on donanemab. PROMINENT responds with AI-driven tools to identify risks, collect real-world data & support equitable access.
Thanks to Hanneke Rhodius-Meester (AmsterdamUMC & Oslo Univ. Hospital) for sharing her thoughts!
www.ihi-prominent.eu/responding-t...
The European Commission has authorised #lecanemab for treatment of early Alzheimer’s disease under strict conditions. Find out more: www.alzheimer-europe.org/news/europea...
16.04.2025 05:59 — 👍 3 🔁 1 💬 0 📌 0Yup, that's very dangerous stuff - equally great in taste.
11.04.2025 12:07 — 👍 0 🔁 0 💬 0 📌 0In a letter to Commissioner Olivér Várhelyi, Alzheimer Europe urges the European Commission to affirm the European Medicines Agency’s positive opinion on #lecanemab, enabling Europeans to access a first disease-modifying treatment for #Alzheimers disease.
www.alzheimer-europe.org/news/alzheim...
BioArctic AB's partner Eisai today announced that the European Commission (EC) has decided to refer the marketing authorisation approval decision of lecanemab in the EU to the Appeal Committee.
www.prnewswire.com/news-release...
Are you interested in research towards an earlier diagnosis of Alzheimer's disease?
Don't miss this end of project event 25-26 June @ Schloss Birlinghoven, Sankt Augustin (Germany) with leading experts on neurodegeneration research.
Online attendance free of charge ↩️
adis-project.eu/final-sympos...
I'd say one gets used to it, but last minute changes remain stressful. Wishing you great success with your event!
28.03.2025 06:50 — 👍 1 🔁 0 💬 1 📌 0All backoffice programme books look like this :)
27.03.2025 15:35 — 👍 0 🔁 0 💬 1 📌 0🆕 Updated European Public Health Starter Pack with:
🔹 European Patients Forum @eupatientsforum.bsky.social
🔹 Cancer Patients Europe @cancerpatientseu.bsky.social
🔹 Tilly Metz MEP, Vice-Chair of the European Parliament Committee on Public Health (SANT) @tillymetz.bsky.social
go.bsky.app/K2JB6CN
The new Alzheimer Europe Dementia in Europe Magazine features an interview with our Scientific Coordinator Erik Christensen, putting a spotlight on the novel test trio to detect peptide biomarkers for enhanced diagnosis & management of #Alzheimer's disease ⤵️
www.alzheimer-europe.org/sites/defaul...
Closing the LETHE project webinar, Miriam Pannone shares her experience about being involved in an Advisory Board to improve dementia research. #PublicInvolvement #LETHEproject
14.03.2025 10:20 — 👍 0 🔁 0 💬 0 📌 0Now speaking at the LETHE project webinar, Jeroen Bruinsma Maastricht Uni discusses why changing behaviour to reduce dementia risk is challenging. #DementiaRiskReduction #PublicInvolvement #LETHEproject
14.03.2025 10:04 — 👍 0 🔁 0 💬 0 📌 0Continuing the LETHE project webinar, Soraya Moradi Bachiller Alzheimer Europe shares her experience in involving the public in dementia risk disclosure. #PublicInvolvement #DementiaAwareness #LETHEproject
14.03.2025 09:53 — 👍 0 🔁 0 💬 0 📌 0Up next in the LETHE project webinar: Francesca Mangialasche from World-Wide FINGERS presents how Public Involvement enhances dementia risk reduction research. #PublicInvolvement #DementiaPrevention #LETHEproject
14.03.2025 09:50 — 👍 0 🔁 0 💬 0 📌 0Kicking off the LETHE project webinar, Ana Diaz Ponce Alzheimer Europe outlines why Public Involvement matters & how it shapes dementia research. #PublicInvolvement #DementiaRiskReduction #LETHEproject
14.03.2025 09:35 — 👍 0 🔁 0 💬 0 📌 0🧠 In #BrainAwarenessWeek, take a deep dive into the impact of IMI and IHI projects on #Alzheimer's disease 👉 europa.eu/!MbFHv6
#IHITransformingHealth #HorizonEU #health #research #dementia
Advances in neuroimaging offer new avenues for earlier detection of Alzheimer’s disease.
Oriol Grau (Barcelonaβeta Brain Research Center) discusses his work in the @ihieurope.bsky.social funded @ihi-prominent.bsky.social project. #BrainAwarenessWeek 🔗 www.ihi-prominent.eu/research-beh...
Welcome to new followers! Please tag your suggestions for #Care leaders and innovators who should be included in this list! Don’t be shy about nominating yourselves too!! #CareInnovation #SocialCare #Gerontology #Geriatrics #Dementia #Disabilty #PublicHealth #PrimaryCare #MedTech
20.11.2024 11:37 — 👍 11 🔁 2 💬 2 📌 0Thank you! It’s much appreciated.
10.03.2025 16:46 — 👍 0 🔁 0 💬 0 📌 0